The Columbia Biomedical Technology Accelerator | Columbia BiomedX (formally Columbia-Coulter Translational Research Partnership) aims to catalyze the advancement of biomedical innovations by providing funding, education, resources and mentorship to interdisciplinary teams of clinicians, engineers, scientists and students working to develop solutions to clinical unmet needs, with the ultimate goal of bringing innovative research out of the lab to benefit society. Project support is expected to serve as a bridge to commercial investment, with awards granted to perform specific tasks needed to validate a commercial hypothesis (vs. a scientific hypothesis). PRE-PROPOSALS due by Nov 15.
Visit www.columbiabiomedx.com for more details.
The most recently funded projects span a broad range of topics and scientific areas, including development of a reparative patch for herniated discs, a software-based analysis process to generate a velocity map of atrial fibrillation, an improved cell production system for cancer immunotherapy, a storage and transportation device for fresh osteochondral allografts, novel methods for allograft bending and engineering allografts for knee repair, and software for analyzing core infarct volume in strokes.
Projects are selected for their commercialization potential, and ultimately their potential to improve human health. Projects that propose to undertake discovery research will not be selected. Successful proposals must be translational in nature, i.e. they must focus on efforts to translate research results into practical clinical application.
If you received an award from the Columbia Biomedical Technology Accelerator in previous years (formerly the Columbia-Coulter Translational Research Partnership), you may be eligible to apply for additional funding to support your project. Such additional funding is contingent on successful achievement of your previous milestones and demonstration of compelling market feedback requiring additional technical development, among other factors. To explore further, please contact us at biomedx@columbia.edu.
Visit www.columbiabiomedx.com for more details.
The most recently funded projects span a broad range of topics and scientific areas, including development of a reparative patch for herniated discs, a software-based analysis process to generate a velocity map of atrial fibrillation, an improved cell production system for cancer immunotherapy, a storage and transportation device for fresh osteochondral allografts, novel methods for allograft bending and engineering allografts for knee repair, and software for analyzing core infarct volume in strokes.
Projects are selected for their commercialization potential, and ultimately their potential to improve human health. Projects that propose to undertake discovery research will not be selected. Successful proposals must be translational in nature, i.e. they must focus on efforts to translate research results into practical clinical application.
If you received an award from the Columbia Biomedical Technology Accelerator in previous years (formerly the Columbia-Coulter Translational Research Partnership), you may be eligible to apply for additional funding to support your project. Such additional funding is contingent on successful achievement of your previous milestones and demonstration of compelling market feedback requiring additional technical development, among other factors. To explore further, please contact us at biomedx@columbia.edu.